Patient and Provider Assessment of Lipid Management Registry "PALM"
Completed
Phase N/A Results N/ASummary of Purpose
The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-lowering therapies given the new ACC/AHA guideline recommendations. The PALM Registry hopes to allow for the design...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 15 February 2016.
1 May 2015 | 9 Jan 2015 | 1 Feb 2016 | 1 Feb 2016 | 1 Jan 2016 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Observation: Cohort
- Perspective: Cross-Sectional
- Sampling: Non-Probability Sample
Contacts
- Laura Webb, BS
laura.webb@dm.duke.edu 919-668-8977
- Jason Blevins, MPH
jason.blevins@dm.duke.edu 919-668-8640
View Trial Locations
Recruitment
- Enrollment: 7,658
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 14 locations, 1 country
Principal Investigators
- Eric Peterson, MD
- Tracy Wang, MD
Duke Clinical Research Institute